+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Capricor Therapeutics - logo

Capricor Therapeutics focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company's development stage drug candidates for cardiovascular diseases include CAP-1002 and enderitide, which are in Phase II clinical trials. It is also developing Exosomes for the treatment of cardiovascular and non-cardiovascular diseases. The company was founded in 2005 and is headquartered in Beverly Hills, California.

Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028

  • Report
  • September 2024
  • 167 Pages
  • Global
From
From
From
Duchenne Muscular Dystrophy Global Market Report 2024 - Product Thumbnail Image

Duchenne Muscular Dystrophy Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Duchenne Muscular Dystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
From
Musculoskeletal Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Musculoskeletal Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 250 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 300 Pages
  • Global
From
From
From
From
Loading Indicator